[1] Woodcock J, LaVange LM. Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both. N Engl J Med 2017;377:62–70 10.1056/NEJMra1510062 [28679092]
[2] Berry SM, Connor JT, Lewis RJ. The platform trial: an efficient strategy for evaluating multiple treatments. JAMA 2015;313:1619–20 10.1001/jama.2015.2316 [25799162]
[3] Park JJH, Harari O, Dron L, et al. An overview of platform trials with a checklist for clinical readers. Journal of Clinical Epidemiology 2020;125:1–8 10.1016/j.jclinepi.2020.04.025 [32416336]
[4] Park JJH, Harari O, Dron L, et al. An overview of platform trials with a checklist for clinical readers. J Clin Epidemiol 2020;125:1–8 10.1016/j.jclinepi.2020.04.025
[5] Barker A, Sigman C, Kelloff G, et al. I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy. Clin Pharmacol Ther 2009;86:97–100 10.1038/clpt.2009.68
[6] Park JJH, Siden E, Zoratti MJ, et al. Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols. Trials 2019;20:572 10.1186/s13063-019-3664-1 [31533793]
[7] James ND, Sydes MR, Clarke NW, et al. STAMPEDE: Systemic Therapy for Advancing or Metastatic Prostate Cancer — A Multi-Arm Multi-Stage Randomised Controlled Trial. Clinical Oncology 2008;20:577–81 10.1016/j.clon.2008.07.002
[8] LaVange L, Adam SJ, Currier JS, et al. Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics. Ann Intern Med 2021;174:1293–300 10.7326/M21-1269
[9] Angus DC, Berry S, Lewis RJ, et al. The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design. Ann Am Thorac Soc 2020;17:879–91 10.1513/AnnalsATS.202003-192SD [32267771]
[10] Pessoa-Amorim G, Campbell M, Fletcher L, et al. Making trials part of good clinical care: lessons from the RECOVERY trial. Future Healthc J 2021;8:e243-e250 10.7861/fhj.2021-0083 [34286192]
[11] Dodd LE, Freidlin B, Korn EL. Platform Trials - Beware the Noncomparable Control Group. N Engl J Med 2021;384:1572–73 10.1056/NEJMc2102446 [33882210]
[12] Park JJH, Harari O, Dron L, et al. An overview of platform trials with a checklist for clinical readers. J Clin Epidemiol 2020;125:1–8 10.1016/j.jclinepi.2020.04.025
[13] Collignon O, Gartner C, Haidich A-B, et al. Current Statistical Considerations and Regulatory Perspectives on the Planning of Confirmatory Basket, Umbrella, and Platform Trials. Clin Pharmacol Ther 2020;107:1059–67 10.1002/cpt.1804
[14] Choodari-Oskooei B, Bratton DJ, Gannon MR, et al. Adding new experimental arms to randomised clinical trials: Impact on error rates. Clin Trials 2020;17:273–84 10.1177/1740774520904346
[15] James ND, Bono JS de, Spears MR, et al. Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy. N Engl J Med 2017;377:338–51 10.1056/NEJMoa1702900 [28578639]
[16] Sydes MR, Parmar MKB, James ND, et al. Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial. Trials 2009;10:39 10.1186/1745-6215-10-39 [19519885]
[17] James ND, Sydes MR, Clarke NW, et al. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. The Lancet 2016;387:1163–77 10.1016/S0140-6736(15)01037-5
[18] Parmar MKB, Sydes MR, Cafferty FH, et al. Testing many treatments within a single protocol over 10 years at MRC CTU at UCL: Multi-arm, multi stage platform, umbrella and basket protocols. Clin Trials 2017;14:451–61 10.1177/1740774517725697
[19] Normand S-LT. The RECOVERY Platform. New Engl J Med 2021;384:757–58 10.1056/NEJMe2025674
[20] Horby PW, Mafham M, Bell JL, et al. Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet 2020;396:1345–52 10.1016/S0140-6736(20)32013-4
[21] Horby P, Lim WS, Emberson JR, et al. Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. N Engl J Med 2020 10.1056/NEJMoa2021436 [32678530]
[22] Siden EG, Park JJ, Zoratti MJ, et al. Reporting of master protocols towards a standardized approach: A systematic review. Contemp Clin Trials Commun 2019;15:100406 10.1016/j.conctc.2019.100406 [31334382]
